Salubris Biotherapeutics Inc

This study tests a new drug called JK07 in 282 adults aged 18-85 with chronic heart failure. The goal is to see if JK07 can safely improve heart function. Participants are divided into two groups based on their heart's pumping ability. The study is double-blind, meaning neither p…

This study was designed to test the safety and effects of a drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll about 20 to 30 adults aged 18 to 85. However, the trial was withdrawn before any participants we…